Absci Corporation ABSI Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Intrinsic Value

Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Intrinsic Value at other companies

ADMA BiologicsADMA

——

PrecigenPGEN

——

Guardant HealthGH

——

Twist Bioscience CorporationTWST

——

Other financials

Income statement

See full

Revenue$215.0K-81.8%

Operating income-$30.8M-11.2%

Net income-$29.6M-12.3%

EPS (diluted)-$0.19+9.5%

Balance sheet

See full

Cash & equivalents$9.7M-84.9%

Total debt$4.0M-37.2%

Total equity$172.0M-13.5%

Total assets$195.6M-15.9%

Cash flow

See full

Operating cash flow-$26.3M-20.5%

CapEx$30.0K+20.0%

Free cash flow-$26.3M-20.5%

Valuation

See full

Market cap$1.57B+341%

Enterprise value$1.57B+425%

P/S855.5×+782×

Profitability

See full

Operating margin-6,723%-14,525pp

Net margin-6,450.8%-13,699pp

FCF margin-5,365.2%-9,300pp

Returns & leverage

See full

Return on equity-63.9%+28.0pp

Debt / equity0×0.0×

Current ratio6.6×+0.9×

Where this comes from

Reported directly by Absci Corporation in its filing.

Tagged under the XBRL concept us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1.

The official record: Absci Corporation’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Absci Corporation's share-based compensation arrangement by share-based payment award, options, exercisable, intrinsic value.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Absci Corporation's share-based compensation arrangement by share-based payment award, options, exercisable, intrinsic value?: Absci Corporation (ABSI) reported share-based compensation arrangement by share-based payment award, options, exercisable, intrinsic value of $5.72M in Q1 2026.
How has Absci Corporation's share-based compensation arrangement by share-based payment award, options, exercisable, intrinsic value changed year-over-year?: Absci Corporation's share-based compensation arrangement by share-based payment award, options, exercisable, intrinsic value increased by 61.6% year-over-year, from $3.54M to $5.72M.